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ABSTRACT
COMPUTATIONAL EVALUATION OF SHEAR STRESS AND
RESTENOSIS IN STENTED CORONARY ARTERIES USING
OPTICAL COHERENCE TOMOGRAPHY

Joshua K. Hughey

Marquette University, 2014

The cause of coronary artery neointimal thickness (NT) leading to restenosis in
~10% of drug-eluting stents (DES) is unknown, but adverse wall shear stress (WSS) may
contribute. Prior studies comparing WSS to restenosis for first generation DES yielded
conflicting results, and cited different mechanisms of action for DES agents. Studies to
date have not accounted for stent geometry, which dictates local WSS patterns
influencing drug concentration. The objective of this investigation was to evaluate current
generation stent platforms via their WSS patterns and their respective impact on NT.
We prospectively enrolled 19 patients, who were randomized to thin-strut (81μm)
2-link Promus element (PE: n=7), thin-strut 3-link Xience Prime (XP: n=6), or thick-strut
(145μm) 2-link Nobori stents (NO: n=6), and underwent optical coherence tomography
(OCT) and coronary CT angiography (CTA) post-stenting (PS) and after 9-months
follow-up (FU). PS and FU WSS were calculated using computational fluid dynamics
(CFD) simulations of patient-specific 3D arteries reconstructed by the fusion of OCT and
CTA data, and normalized to WSS in the proximal unstented region.
Stent-to-vessel area ratios were less in PE and XP than NO (0.24±0.04 and
0.21±0.03 vs. 0.34±0.04, respectively; P<0.05). The difference between the NO and XP
was significant. PS normalized stent-induced low WSS area/stent length was least in PE,
followed by XP and NO (1.05±0.27, 1.10±0.20 and 2.00±0.41 mm2/mm, respectively,
P<0.05). The difference between the NO and PE was significant. When combining the
data from the proximal, middle, and distal regions, an inverse correlation between PS
WSS and NT at FU was greatest for the NO (-0.019±0.001 mm/Pa) followed by PE (0.017±0.003 mm/Pa) and XP (-0.008±-0.003 mm/Pa). The difference in inverse
correlation between the NO and XP was significant.
The difference in correlations of PS normalized WSS and NT at FU between the
biolimus-eluting NO and everlimus-eluting XP stents may be attributed to the
mechanisms of action for the specific elution agents. CFD simulations using OCT and
CTA suggest that DES with thicker struts and a greater stent-to-vessel area ratio produce
more adverse WSS, which may lead to a higher risk for restenosis and be influenced by
DES agent.

i

ACKNOWLEDGEMENTS

Joshua K. Hughey

First, I am deeply thankful for the opportunity my advisor and mentor, Dr.
LaDisa, provided me by allowing me to join his lab. It was not a week after we spoke on
the phone for the first time that he gave me a tour around Marquette and offered me a
graduate research position. His passion and drive for cardiovascular research is passed
on to everyone participating in his lab or coursework. He has provided guidance both
academically and professionally and I look forward to continuing the relationship in the
future.
I would like to thank all my committee members, Dr. Ellwein, Dr. Otake, and Dr.
Gilat-Schmidt, for the time and effort put forth to advance my research presented in this
thesis.
I am extremely grateful for the assistance of Dr. Ellwein throughout this project.
Not only did she create the principal algorithm used for artery reconstruction, she was
always willing to field the endless amount of questions I had over the past two years. Her
assistance was greatly appreciated when troubleshooting code and creating new
protocols.
I would like to thank Dr. Otake for his collaboration during this project. His
insight when attempting to analyze and understand the data and results was tremendously
valuable. Despite the time difference, Dr. Otake and his entire team at Kobe University
were always able to resolve any issue or discrepancy with the data in short order.
Without their hard work, this collaboration would not be possible.
I would like to thank Dr. Gilat-Schmidt. When participating in her image
processing course, she related specific concepts to different areas of research including
cardiovascular research. Algorithms generated with her help throughout her course are
not only used in this specific project, but in projects throughout our entire research lab.
From the University of Missouri, I would like to thank Dr. John Viator. He
graciously allowed me to join his lab as an undergraduate. While in his lab, not only did
he guide me in my specific research project, he taught me how to perform scientific
research. Without his guidance as an undergraduate, I would not have been equipped to
become a graduate researcher.
I want to thank all my friends in the Laboratory for Translational, Experimental,
and Computational Cardiovascular Research as well as the entire Biomedical Engineering
Department. I have enjoyed our intellectual discussions regarding research as well as all
the fun we had outside of school. I would also like to thank Kelsey Allison. From my
undergraduate to graduate coursework and research, she has always been there to support
me.
I want to thank my family. First, I want to thank my siblings, Jake and Becca.
Whether it was on an athletic field, in the class room, or in my field of research, they
have always been there to support me. For this love and support, I am forever grateful.
Finally, I want to thank my parents, Ken and Judy. None of my success would have been

ii
possible without their love and guidance. While my debt to you will forever be endless, I
hope this piece of work is something you can look back on and be proud of.

iii
TABLE OF CONTENTS
ACKNOWLEDGEMENTS ................................................................................................. i
LIST OF FIGURES ........................................................................................................... vi
LIST OF ACRONYMS .................................................................................................... xii
CHAPTER 1: INTRODUCTION AND SPECIFIC AIMS ............................................... 1
1.1 Cardiovascular Disease ..................................................................................... 1
1.2 Treatment Methods for Cardiovascular Disease ............................................... 2
1.3 Restenosis and Thrombosis After Stenting ....................................................... 4
1.4 Restenosis Causing Blood Flow Alterations..................................................... 4
1.5 Methods of Evaluating the Effectiveness of Stents .......................................... 5
1.5.1 Intravascular Ultrasound .................................................................... 6
1.5.2 Optical Coherence Tomography ........................................................ 7
1.6 CFD as a Tool for Modeling Blood Flow ......................................................... 8
1.7 Objective and Specific Aims ............................................................................ 9
1.7.1 Aim 1: Confirm Previous Studies Relating Low WSS and Stent
Geometry................................................................................................... 13
1.7.2 Aim 2: Comparison Between Post-Stent and Follow-up Low
Normalized WSS ...................................................................................... 13
1.7.3 Aim 3: Evaluate Post-Stent WSS and Follow-up NT ...................... 14
CHAPTER 2: METHODS ............................................................................................... 15
2.1 Data Acquisition ............................................................................................. 15
2.2 Patient-Specific Vessel Reconstruction .......................................................... 16
2.2.1 Image Processing ............................................................................. 16
2.2.2 Wire Pathway Reconstruction.......................................................... 17

iv
2.2.3 Segment Registration ....................................................................... 17
2.2.4 Model Assembly .............................................................................. 19
2.3 Computational Stent Implantation .................................................................. 20
2.4 Steps Performed to Assure Accuracy During Vessel Reconstruction ............ 22
2.5 Specification of CFD Boundaries Conditions and Simulation Parameters .... 26
2.6 Anisotropic Meshing of Patient-Specific Models ........................................... 30
2.7 Data Normalization ......................................................................................... 30
2.8 Data Quantification Points .............................................................................. 32
2.8.1 Regional Quantification ................................................................... 32
2.8.2 Local Quantification ........................................................................ 34
2.9 Statistical Analysis .......................................................................................... 37
CHAPTER 3: RESULTS ................................................................................................. 39
3.1 Patient-Specific WSS and OSI Results ........................................................... 39
3.1.1 Post-Stenting Results ....................................................................... 39
3.1.2 Follow-up Results ............................................................................ 46
3.2 Post-Stenting WSS and Follow-Up Tissue Growth ........................................ 54
3.2.1 Comparison Between Post-Stenting WSS and Follow-Up Neointimal
Tissue ........................................................................................................ 54
3.2.2 Total Neointimal Growth at Follow-Up .......................................... 59
CHAPTER 4: DISCUSSION ........................................................................................... 61
4.1 Review of Specific Aims and Summary of Major Findings ........................... 61
4.2 Relationship to Previous Work Underscoring Unique Contributions............. 64
4.3 Limitations ...................................................................................................... 67
4.4 Future Directions ............................................................................................ 68

v
BIBLIOGRAPHY ............................................................................................................. 69
APPENDIX……. .............................................................................................................. 76

vi
LIST OF FIGURES

Figure 1: Normal blood flow in a healthy artery (A) compared to a vessel with
atherosclerosis (B). Image obtained from the National Heart Lung and Blood Institute. . 2
Figure 2: OCT (right) has ten times the spatial resolution compared to IVUS (left). IVUS
image obtained from Nissen; Journal of the American Heart Association 2001. ............... 8
Figure 3: Promus element stent- Boston Scientific (top, multivu.com). Xience prime
stent- Abbott Vascular (middle, fda.gov). Nobori stent- Temuro (bottom, terumoeurope.com). ..................................................................................................................... 11
Figure 4: a) OCT image with lumen (green) and stent (purple) contours. b) and c) Stent
and lumen contours, respectively, isolated from RGB image using thresholding
previously described by Ellwein et al in CVET 2011. d) and e) Pixel locations for stent
and lumen contours, respectively. (Blue point = OCT image center, black dot = contour
center). .............................................................................................................................. 17
Figure 5: Segments registered on the wire pathway (black line) according to vessel
landmarks where possible. Remaining segments are then oriented to wire pathway and
rotated such that segment centroids align with the vessel centerline (blue line). Vector
from the image centroid to the upper-left hand corner was also tracked and plotted (red).
........................................................................................................................................... 19
Figure 6: Combined segments from CT and OCT (a) are lofted along with the branch
segments to form a Parasolid model (b). .......................................................................... 20
Figure 7: Method of virtual stent implantation. Solid models of the outer surface of the
stent and vessel lumen (e) were lofted from the purple and green contours of the OCT
images (a). The stent model was used to create a shell with the thickness equal to that of
the stent (b). The shell was intersected with the thick stent model (c) to create a patientspecific stent model (d). Subtracting the patient-specific stent model (d) from the lumen
model (e) generated a computational representation of the blood flow domain (f). ......... 21
Figure 8: Model produced from Gundert et al that does not account for malapposed struts
(left). Model produced from current method that can create malapposed struts (right). . 22
Figure 9: Processes for assuring accuracy while creating patient-specific coronary
models. .............................................................................................................................. 23

vii
Figure 10: Abnormality (i.e. dissection) in the lumen contour that requires an increase in
segment points. ................................................................................................................. 24
Figure 11: OCT image (left). Slice from initial virtual stent implantation with struts not
matching OCT image (middle). Slice after applying a specific rotation to the stent in
Solidworks to better match the OCT image (right). * = guidewire artifact.  = stent strut.
........................................................................................................................................... 26
Figure 12: Using flow waveform, blood pressure, impedance spectra, and RCR
parameters to replicate physiologic behavior (Fm=mean flow, Pm=mean pressure,
Rc=characteristic impedance, Rd=distal resistance, C=capacitance, PPd=pulse pressure
predicted by model, PPa=pulse pressure method). Image obtained from Westerhof,
American Phys. Society, 1999. ......................................................................................... 29
Figure 13: Different values of WSS proximal to the stented region for three different
patients. ............................................................................................................................. 31
Figure 14: Low normalized WSS distributions produced by the vessel (left) compared to
distributions produced by the vessel and stent geometry (right). ..................................... 33
Figure 15: Proximal, middle, and distal regions with maximum scaffolding that were
isolated in an effort to correlate post-stenting WSS and follow-up NT. .......................... 35
Figure 16: WSS results from CFD with the zero degree position line (epicardial surface)
from unwrapping (a). Zero degree line with Paraview slice (b). OCT image (c) and
Paraview slice (d) are isolated to create their respective contours (e and f, respectively).
Rotations θ and α are determined for the OCT contour and Paraview slice between the
initial zero degree point and the epicardial surface. Rotations are applied to the lumen
contour (g) and Paraview slice (h) making the final zero degree position spatially
consistent. 90°, 180°, and 270° positions are plotted to assure all points are spatially
consistent........................................................................................................................... 37
Figure 17: Post-stenting distributions of low normalized WSS........................................ 40
Figure 18: Post-stenting distributions of OSI > 0.1. ......................................................... 41
Figure 19: Comparison of the stent-to-vessel area ratio, *=significance (mean±SEM). .. 42
Figure 20: Comparison of the post-stenting normalized area of low WSS as a percentage
of the entire vessel (mean±SEM). ..................................................................................... 43

viii
Figure 21: Comparison of the post-stenting normalized stent-induced area of low WSS
(mean±SEM). .................................................................................................................... 44
Figure 22: Comparison of the post-stenting normalized stent-induced area of low WSS
per stent length, *=significance (mean±SEM).................................................................. 45
Figure 23: Comparison of the post-stenting stent-induced OSI greater than 0.1,
*=significance (mean±SEM). ........................................................................................... 46
Figure 24: Follow-up distributions of low normalized WSS. ........................................... 47
Figure 25: Follow-up distributions of OSI > 0.1. ............................................................. 48
Figure 26: Comparison of the follow-up normalized area of low WSS as a percentage of
the entire vessel (mean±SEM). ......................................................................................... 49
Figure 27: Comparison of the follow-up normalized stent-induced area of low WSS per
stent length (mean±SEM). ................................................................................................ 50
Figure 28: Post-stenting and follow-up distributions of low normalized WSS. ............... 51
Figure 29: Comparison of the post-stenting and follow-up normalized area of low WSS
as a percentage of the entire vessel, *=significance (mean±SEM). .................................. 52
Figure 30: Comparison of the follow-up OSI greater than 0.1 (mean±SEM). ................. 53
Figure 31: Comparison between post-stenting and follow-up OSI greater than 0.1
(mean±SEM). .................................................................................................................... 54
Figure 32: OCT image at follow-up (a) with circumferential NT measurements starting at
the zero degree position (b). Paraview slice at post-stenting (c) with circumferential WSS
measurements starting at the zero degree position (d). Correlation between post-stenting
WSS and NT at follow-up (e). .......................................................................................... 55
Figure 33: Distal region comparison of inverse correlations of post-stenting WSS and
follow-up neointimal thickness represented by the r-value and slope from regression
analysis (mean±SEM). ...................................................................................................... 56

ix
Figure 34: Middle region comparison of inverse correlations of post-stenting WSS and
follow-up neointimal thickness represented by the r-value and slope from regression
analysis (mean±SEM). ...................................................................................................... 56
Figure 35: Proximal region comparison of inverse correlations of post-stenting WSS and
follow-up neointimal thickness represented by the r-value and slope from regression
analysis (mean±SEM). ...................................................................................................... 57
Figure 36: High WSS region comparison of inverse correlations of post-stenting WSS
and follow-up neointimal thickness represented by the r-value and slope from regression
analysis (mean±SEM). ...................................................................................................... 57
Figure 37: Low WSS region comparison of inverse correlations of post-stenting WSS and
follow-up neointimal thickness represented by the r-value and slope from regression
analysis (mean±SEM). ...................................................................................................... 58
Figure 38: Combined proximal, middle, and distal regions comparison of inverse
correlations of post-stenting WSS and follow-up neointimal thickness represented by the
r-value and slope from regression analysis, *=significance (mean±SEM)....................... 58
Figure 39: Comparison of the change in volume from post-stenting to follow-up
(mean±SEM). .................................................................................................................... 59
Figure 40: Comparison of the change in volume from post-stenting to follow-up as a
percent of post-stenting volume (mean±SEM). ................................................................ 60
Figure 41: 3D volume in Volview showing the size in voxels and image spacing. ......... 79
Figure 42: Using ImageJ, determine the Image Position for the most superior image. .... 79
Figure 43: X, Y, and Z shifts output in Matlab. ................................................................ 80
Figure 44: Naming the slice and creating the segment matrix......................................... 81
Figure 45: Saving the’ vesseln_sparse’ or ‘vesseln_one’, depending if the image has an
anomaly. ............................................................................................................................ 83
Figure 46: Adjusting the number of points being saved for a contour. ........................... 84

x
Figure 47: Illustrating the X, Y, and Z coordinates of contours. ..................................... 85
Figure 48: Determining the landmark positions in ITK-Snap and inserting them into
Matlab. .............................................................................................................................. 87
Figure 49: Determining which OCT images correspond to the landmark positions. ...... 88
Figure 50: Creating the matrices for find_pathpoints.m. ................................................. 89
Figure 51: Adding the mm/pixel ratio. ............................................................................ 91
Figure 52: Setting the candidate points (circled) for the landmark positions. ................. 91
Figure 53: Transducer candidate points for the proximal and distal regions. .................. 93
Figure 54: Setting up for-loops to properly determine transducer pathway. ................... 94
Figure 55: Final rotated segments with the centerline (blue) and transducer pathway
(black). Also, the upper-left hand corner of the images is tracked and plotted. .............. 99
Figure 56: Naming the group for Simvascular. ............................................................. 100
Figure 57: Naming the groups in the group_contents file. ............................................ 100
Figure 58: Truncating the transducer pathway based on the stented region. ................. 102
Figure 59: Inputs for orient.m. ....................................................................................... 105
Figure 60: Setting 's' to be the OCT image being quantified. ........................................ 107
Figure 61: Determing 'deg_shift', if the circumferential shift was applied in the wrong
direction, comment out 'deg_shift' that was used and un-comment the other one. Note,
one instance must be commented. .................................................................................. 107
Figure 62: Final zero and epicardial surface (lime green point) are in the same location.
Initial zero degree location (forest green point) and final 90 degree locations (blue point)
are also plotted. ............................................................................................................... 108

xi
Figure 63: Example of shift being applied in the wrong direction. Final zero degree
location (black point) and epicardial surface (lime green point) do not overlap. ........... 109
Figure 64: WSS versus circumferential location plot. ................................................... 110
Figure 65: Inputs for thickness.m program. ................................................................... 111
Figure 66: Thickness versus circumferential location plot. ........................................... 112

xii
LIST OF ACRONYMS
(in order of appearance)
CVD = cardiovascular disease
CAD = coronary artery disease
LDL = low density lipoprotein

FD-OCT = frequency-domain optical
coherence tomography
CTA = computed tomography
angiography

BMS = bare-metal stent
SEM = standard error of the mean
DES = drug-eluting stent
PTCA = percutaneous transluminal
coronary angioplasty
NH = neointimal hyperplasia
NT = neointimal thickness
LST = late-stent thrombosis
WSS = wall shear stress
OSI = oscillatory shear index
OCT = optical coherence tomography
CFD = computational fluid dynamics
IVUS = intravascular ultrasound
TD-OCT = time-domain optical
coherence tomography

1

Chapter 1
Introduction and Specific Aims
1.1 Cardiovascular Disease
According to the American Heart Association, approximately 84 million
Americans have some form of cardiovascular disease (CVD)[1]. The most prevalent
form of CVD is coronary artery disease (CAD). CAD affects approximately 51% of
those suffering from CVD and is the leading cause of death in the United States[1].
The coronary arteries are the heart’s main source of blood, oxygen, and nutrients.
CAD is caused by damage or disease to these vessels. The main contributor to CAD is
atherosclerosis, defined as the hardening and narrowing of a blood vessel due to plaque
build-up (Figure 1)[2]. The process of atherosclerosis begins when the endothelial cells
lining the inside of the vessel wall are damaged. This damage can be caused by many
factors including, but not limited to, high blood pressure, smoking, and elevated
cholesterol levels. In particular, low-density lipoproteins (LDL) invade the damaged
endothelium and enter the vessel wall[3]. Over time, the combination of LDL cholesterol
and cells such as macrophages and smooth muscle cells form a plaque protruding from
the vessel wall into the region available for blood flow. If this protrusion becomes severe
enough, blood flow to the heart can be completely occluded resulting in myocardial
infarction or death. Alternatively, the plaque may rupture, causing a local inflammatory
reaction that may occlude the artery.
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Figure 1: Normal blood flow in a healthy artery (A) compared to a vessel with atherosclerosis (B). Image obtained
from the National Heart Lung and Blood Institute.

1.2 Treatment Methods for Cardiovascular Disease
Today, the standard form of treatment for CAD is stenting. Stents act as
scaffolding mechanisms and are permanently embedded into the vessel wall in an effort
to eliminate the effects of the plaque build-up. There are two main types of balloonexpandable stents, bare metal (BMS) and drug eluting (DES). A brief review of both
technologies is provided below.
The introduction of BMS as a treatment method was a great advance compared to
traditional percutaneous transluminal coronary angioplasty (PTCA). PTCA is a technique
in which a deflated balloon is passed through the artery via a guide wire and catheter to
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the region of plaque. The balloon is then inflated to a specific pressure in an effort to
expand the local atherosclerotic plaque and improve blood flow. While PTCA is often
used today as a tool for predilation before stenting, it alone is not a sufficient treatment
method due to restenosis rates of 30-40%[4]. Restenosis is defined as a reduction in the
luminal diameter of more than 50%[5]. Very recent studies suggest that drug-eluting
balloons may reduce the rate of restenosis after PTCA, but long-term data is not yet
available[6], [7]. Stents were invented to overcome the limitations of traditional PTCA
and BMS were used in over 80% of all coronary interventions by 1999[4]. While BMS
continued to grow in popularity as a treatment method, restenosis with the need for
revascularization still had an occurrence rate of 20-30%[8].
In an effort to further reduce the occurrence of restenosis and amount of
revascularization procedures, DES were introduced in 2001[9]. DES are similar to BMS
in scaffold design and fabrication material such as stainless steel or cobalt chromium.
However, DES contain a polymer coating of an anti-proliferative agent such as
everolimus, biolimus A9, or paclitaxel that is released locally to prevent restenosis. The
local drug delivery approach of DES provides a major advantage over systemic drug
delivery that was often used previously. Patients were not able to tolerate the toxic doses
of the drug when delivered systemically[10]. In contrast, the drug is released locally with
DES in order to concentrate the drug to the target sight.
Though DES have reduced restenosis rates, studies have shown they do not
improve the incidence of late stent thrombosis (LST). LST is defined as blood clot
forming 30 days to 1 year after the stent is implanted. This LST along with restenosis are
limiting factors in the success of DES. Both factors are reviewed below.
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1.3 Restenosis and Thrombosis After Stenting

As previously mentioned, restenosis is the over-growth of tissue after stenting and
is can be caused by an exaggerated inflammatory response. The inflammatory response
can lead to the formation neointimal hyperplasia (NH). NH is defined as an exaggerated
type of healing that occurs in the lining of blood vessels[11]. NH causes an increased
neointimal thickness (NT) in the blood vessel lining that can narrow the vessel and
obstruct blood flow. Long-term studies indicate restenosis rates are reduced to 4-6% with
DES, however, studies have shown DES are more susceptible to LST[12]. The LST has
the potential to establish a blockage in the artery being treated, or a downstream vessel,
and can therefore lead to a myocardial infarction and death. This increase in incidence of
LST in DES has been attributed to suboptimal endothelial cell coverage[13],[14]. The
incidence rate of LST after DES implantation is only 0.5-2%, however, at one point it
was reported that there was as high as a 50% mortality rate for patients who do
experience LST[15].

1.4 Restenosis Causing Blood Flow Alterations
There are several factors influencing restenosis, including local flow disturbances.
These disturbances are caused, at least in part, by altered geometry within the artery (i.e.
flow domain) triggered by stenting. Geometry is altered by the fact that the stent must be
over-expanded relative to the native artery, as well as the geometric intricacies of the
stent itself. Hemodynamic indices such as wall shear stress (WSS) and oscillatory shear
index (OSI) have been correlated to NH, specifically, areas of low WSS and high
OSI[16].
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WSS is described as the frictional force acting tangentially from flowing fluid, in
this case, blood. For simple flow, WSS can be calculated directly from the near wall
velocity gradient as shown in Equation 1 where τ is wall shear stress, µ is dynamic
viscosity, u is the velocity of the fluid close to the wall, and y is the distance from the
wall.
Equation 1: Wall shear stress
From Equation 1, one can conclude that the closer to the wall that the velocity can be
determined, the more accurate the WSS calculation will be. Error related to this
calculation is influenced by the technique used to obtain the near-wall velocity
measurement, specifically, how close to the wall a given technique can resolve fluid
velocity. Common techniques include Doppler and MRI; however, these techniques are
only able to resolve velocity down to 0.9 mm resulting in a poor approximation of
WSS[17]. In contrast, if one can accurately reconstruct a vessel such as a coronary artery
using an imaging modality with higher resolution such as optical coherence tomography
(OCT), computational fluid dynamics (CFD) can likely provide a much better estimate of
WSS. The only limiting factors when calculating the distance from the artery wall with
CFD is the size of the finite element mesh, and, therefore, the computational resources
available to solve the governing equations of fluid flow.

1.5 Methods of Evaluating the Effectiveness of Stents
In order to fully evaluate CAD and effectiveness of stents, one must be able to
make measurements inside the vessel of interest. This is accomplished through medical
imaging such as intravascular ultrasound (IVUS) and OCT. These imaging modalities
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provide the user with the ability to determine the stent and strut placement within the
vessel as well as a measurement of tissue growth over the stent struts (i.e. NT). These
imaging modalities can also be used to create 3D reconstructions of the vessel for
computational blood flow simulations[18],[19],[20],[21].
1.5.1 Intravascular Ultrasound

IVUS is a combination of an echocardiogram and cardiac catheterization. An
ultrasound catheter tip is connected to a guidewire and navigated to the patients’ coronary
artery using angiography techniques. There are two types of IVUS, mechanical and solid
state. Mechanical IVUS uses a mechanical transducer catheter that contains a rotating
ultrasound source. The rotating ultrasound signal covers the entire vessel with no signal
interference. Solid state IVUS uses phased array catheters that contain a flashing
ultrasound source. With solid state IVUS, interference occurs and an area of no
information is generated. The acoustic waves of a frequency usually between 20-40MHz
are emitted from the catheter tip[22]. These waves, primarily, reflect off tissue and return
back to the transducer as echoes or are scattered. The amount of echo returned after
interacting with tissue is dependent on the tissue’s acoustic impedance[23]. This
information is sent from the catheter tip to an external computer that constructs a real
time image of a section of the artery surrounding the catheter tip. This technique
provides the clinician with an image of the inside of the vessel. IVUS has spatial
resolution of 150 microns[24]. Due to the intricacies of a stented coronary artery where
most stent struts (i.e. linkages) are not routinely ≤100 microns, this low resolution can
lead to the loss of spatial information which can be vital when evaluating the efficiency
of the stent and reconstructing the vessels[25]–[28]. However, IVUS permits plaque
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characterization for complete lesion assessment using systems like that sold by Volcano
and Boston Scientific[29], [30].
1.5.2 Optical Coherence Tomography

OCT has shown to have a spatial resolution ten times that of IVUS as seen in
Figure 2. This increased resolution provides improved detail in stented coronary arteries
needed for an accurate reconstruction and analysis of hemodynamic indices from
computational modeling results (i.e. WSS and OSI)[24], [31], [32]. OCT is similar to
ultrasound; however, instead of emitting sound waves, OCT emits near-infrared light into
the vessel. There are two types of OCT, time-domain (TD-OCT) and frequency-domain
(FD-OCT). This study used FD-OCT as it provides improved resolution and acquisition
speed as well as more accurate segmentation of the lumen and stent boundaries used
during the CFD modeling process. The optical diode used in FD-OCT is attached to the
end of a guide catheter and emits a low coherence near-infrared light beam directed
toward the target tissue. The magnitude and location of the backscattered light from the
tissue is interpreted to create an image. This backscattered signal is detected in the
frequency domain. Because the signal is in the frequency domain, the acquisition time is
decreased compared to TD-OCT. Frequency information is acquired with a broadbandwidth light source, charge-coupled device camera, and a spectrometer[33]. The
broadband light source improves the axial resolution compared to TD-OCT; however,
there is also a significant signal drop-off with depth[33]. While OCT allows for an
assessment of coronary disease and the ability to see strut apposition against the vessel
wall, the practice remains scarce in a clinical setting.
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Figure 2: OCT (right) has ten times the spatial resolution compared to IVUS (left). IVUS image
obtained from Nissen; Journal of the American Heart Association 2001.

1.6 CFD as a Tool for Modeling Blood Flow
CFD is an advanced simulation tool commonly used in fluid mechanics to solve
the governing equations of fluid flow using numerical methods and algorithms. CFD is a
useful method for analyzing the effect of stents in coronary arteries given that complex
engineering metrics such as local velocity distributions are difficult to obtain in vivo.
Using CFD, one can quantify key indices of NT and hemodynamic consequences of
stenting including WSS and OSI[16], [19]–[21], [34].
From the simulation results, time-averaged WSS (τmean) is determined as follows.
Total stress on the vessel wall (Equation 2), σ, is the sum of pressure and viscous forces
as seen below where p is pressure, I is the 3x3 identity matrix, µ is viscosity, and ∇u is
the velocity gradient.
Equation 2: Total stress on the wall
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A normal vector (Equation 3), ns, is defined for each point on the luminal surface. The
traction vector, t, is the product of the total stress on the wall (σ) and the normal vector
(ns) as seen below.
Equation 3: Traction vector
Subtracting the normal component of traction isolates the surface vector of traction (ts) as
seen below in Equation 4.
Equation 4: Surface vector of traction
τmean (Equation 5) is defined as the magnitude of the time-averaged surface vector of
traction ts as seen below where T is the period of the cardiac cycle[35].
Equation 5: Time-averaged WSS

∫

As previously mentioned, OSI has also been correlated to NH. OSI is a measure
of directionality of WSS. Lower OSI values indicate WSS is oriented predominately in
the primary direction of blood flow while a value of 0.5 is indicative of bi-directional
WSS with a time-average value of zero over the cardiac cycle. OSI is computed as seen
in Equation 6[35].

Equation 6: Oscillatory shear index

(

| ∫
∫ | |

|

)

1.7 Objective and Specific Aims

There is limited data on the correlation between WSS distributions and NT for
current generation DES. Gaining a better understanding of the relationship between
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adverse WSS distributions and NT for current generation DES has the potential to reduce
the number of revascularization procedures and, in turn, reduce healthcare costs.
The objective of this thesis was to evaluate the effects of three different stents
implanted into coronary arteries on WSS and NT. Specifically, this study will investigate
the effects of the Nobori (Temuro), Promus Element (Boston Scientific), and Xience
Prime (Abbott Vascular) stents as seen in Figure 3 via their WSS distributions
immediately (post-stenting) and 9 months after stent implantation (follow-up) relative to
their respective NT that develops. The objective will be completed using three aims
introduced and discussed beginning in section 1.7.1.
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Figure 3: Promus element stent- Boston Scientific (top, multivu.com). Xience prime stent- Abbott Vascular (middle,
fda.gov). Nobori stent- Temuro (bottom, terumo-europe.com).

The Nobori, Promus Element, and Xience Prime are current generation DES and their
respective specifications including strut thickness, width, angle relative to flow, and drugelution characteristics can be found in Table 1. As the Table 1 illustrates, the Nobori
stent is thicker compared to the Promus Element and Xience Prime stents. Also, stent
geometry is the only differing aspect between the Promus Element and Xience Prime
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stents as the elution agent and coating are equivalent. Outcomes of this study will
improve the understanding of how different stent designs affect NT relative to the
respective anti-proliferative drugs for each DES.
Nobori

Promus Element

Xience Prime

Strut Thickness (mm)

0.135

0.08

0.08

Strut Width (mm)

0.15

0.086

0.09

50.4

52.3

45.7

Biolimus A9

Everolimus

Everolimus

6.9

1.2

0.85

45%†

80%

80%

0.09

0.33-0.5

0.33-0.5

0.1005

0.1014

0.1014

PLA

PMBA+PVDF-HFP

PMBA+PVDF-HFP

Bioabsorbable

Durable

Durable

Abluminal and

Abluminal and

Luminal

Luminal

Angle Relative to
Flow (deg)
Elution Agent
Total Drug Dose
(µg/mm2)
Release – 4 or 12†
weeks
Plasma Concentration
(ng/mL)
Diffusion Coefficient

Polymer

Coated Area

Abluminal

Table 1: Nobori, Promus Element, and Xience Prime stent specifications[36]. PBMA: poly-n-butyl methacrylate;
PVDF-HFP: vinylidene fluoride and hexafluroisopropylene; PLA: poly-lactic acid.
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1.7.1 Aim 1: Confirm Previous Studies Relating Low WSS and Stent Geometry

The first aim of this study is to use patient-specific models to confirm previous
idealized studies regarding stent design characteristics and their effect on adverse WSS
distributions. Stent geometry has been shown to affect the distribution of WSS, and, in
turn, affect NT[16]. Gundert et al created a hierarchy of factors that can result in adverse
WSS distributions by virtually implanting various stents into idealized coronary
arteries[34]. The hierarchy includes strut thickness, stent-to-lumen area ratio, angle of
struts relative to the primary direction of blood flow, and the arrangement of connector
elements[37]. To accomplish aim 1, stents are virtually implanted into patient-specific
reconstructions of coronary arteries based on OCT images. CFD simulations are
performed and areas of low WSS determined.
1.7.2 Aim 2: Comparison Between Post-Stent and Follow-up Low Normalized WSS

The second aim of this study is to compare post-stent normalized low WSS with
follow-up normalized low WSS. During the follow-up period, tissue grows atop and
around the stent struts. In theory, this tissue growth should return the WSS closer to the
artery’s native value, thereby decreasing the consequences of adverse WSS distributions.
Reconstructions of coronary vessels in aim 2 are created at post-stenting and follow-up.
This aim provides analysis of how well the different stent struts are apposed in the vessel
9 months after stent implantation. A stent strut is considered malapposed if it is not flush
against the arterial wall[38]. Also, results from this aim provide overall insight on tissue
growth within the stented region with respect to different stent geometries and elution
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agents. We hypothesize that the thick strutted Nobori will yield greater NT compared to
the thinner strutted Promus Element and Xience Prime.
1.7.3 Aim 3: Evaluate Post-Stent WSS and Follow-up NT

The third and final aim of this study is to evaluate post-stent WSS and follow-up
NT. Adverse distributions of WSS caused by stenting can cause increased NT leading to
restenosis. There have been only a few small studies correlating WSS distributions to NT
for first generation DES, which collectively yielded conflicting results[39]–[41]. OCT
images offer the capability to quantify the arterial response (i.e. vessel damage and NT)
within the stented region and hypothesize associations between WSS post-stenting and
follow-up NT. This approach will help predict how different current generation DES
impact NT.
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Chapter 2
Methods
2.1 Data Acquisition
Computed tomography angiography (CTA) and OCT imaging were performed
immediately after stenting, as well as at 9 months follow-up. CTA is a noninvasive
procedure that enables visualization of the region available to blood flow within coronary
arteries. The acquisition of this data was completed by Dr. Hiromasa Otake and his team
at Kobe University Graduate School of Medicine in Kobe, Japan. This study was
approved by the ethical committee of Kobe University and Institutional Review Board at
Marquette University. CTA was performed using a 320-detector row CTA (Toshiba
Aquilion OneTM, Otawara, Japan) in accordance with guidelines set by the Society of
Cardiovascular Computed Tomography[42]. An intravenous bolus (30-90 ml) of contrast
agent was injected at a flow rate of 0.07 ml/kg/s. The tube current time product was 300400 mAs and a tube voltage of 100 or 120 kVp. Scans were performed using ECG-based
tube current modulation or sequential image acquisition. Transaxial images were
reconstructed with 0.75 millimeter slice thickness and 0.3 millimeter slice increment
using a medium-smooth convolution kernel. Coronary angiography data was visualized
using Volview (Kitware, Clifton, NY). Volview is an open-source volume visualization
system designed for examination of medical data in a research setting. Volview has the
capability to load a wide range of file formats and generate high-quality 3D renderings.
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Specifically, this study used Volview to isolate the stented artery and create 3D volumes
from the CTA data.

2.2 Patient-Specific Vessel Reconstruction
Vessel reconstruction was divided into five steps of image processing, wire
pathway reconstruction, segment registration, model assembly, and stent implantation.
This patient-specific reconstruction process was created and validated by Ellwein et
al[21]. Each of these steps is reviewed below. Additional details and methods developed
for the current work are highlighted.
2.2.1 Image Processing

OCT images were processed using Matlab (MathWorks; Natic, MA). Lumen and
stent contours of the OCT images were first isolated and converted to grayscale. The
headers, footers, and other markings were then masked and a binary image of the
contours was created. The binary images were scaled with a calibration value found
using ImageJ (www.imagej.net). In ImageJ, a line of a known length was placed along
the scale provided on the OCT image. Using ImageJ’s ‘Set Scale’ feature, the length in
pixels of the line, and, in turn, the number of millimeters per pixel for the image were
determined. The pixels of the binary image were then converted to Cartesian coordinates
with the z-coordinate for each image segment representing its pullback distance. This
process can be seen in Figure 4. Finally, the segments were aligned vertically in
succession resulting in a stack of OCT segments positioned with the z-axis intersecting
each segment at its centroid.
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(b)

(d)

(c)

(e)

(a)

Figure 4: a) OCT image with lumen (green) and stent (purple) contours. b) and c) Stent and lumen contours,
respectively, isolated from RGB image using thresholding previously described by Ellwein et al in CVET 2011. d) and
e) Pixel locations for stent and lumen contours, respectively. (Blue point = OCT image center, black dot = contour
center).

2.2.2 Wire Pathway Reconstruction

During OCT data acquisition, the images are obtained orthogonal to the
photodetector at the tip of the imaging wire and do not necessarily lie on the vessel
centerline, or orthogonal to it. Consequently, the wire pullback pathway must be
determined to ensure precise segment registration. The wire pathway with minimum
bending energy was determined by applying a shortest path algorithm to a graph
representation of the artery as previously described in detail by Ellwein et al[21].
2.2.3 Segment Registration
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Segments from the OCT images were registered on the reconstructed wire
pathway according to known vessel landmarks from CTA such as the edge of the stent or
a bifurcation, where available. The remaining segments were positioned longitudinally
according to OCT image spacing. Finally, segments were oriented orthogonal to the wire
pathway and rotated such that their centroids were aligned with a vessel centerline
generated from the CTA data using the open-source software packages ITK-Snap
(www.itksnap.org) and VMTK (www.vmtk.org) as seen in Figure 5. 3D segmentation in
ITK-Snap was performed using intensity regions with a lower threshold of 175 and no
upper threshold, and a snake propagation of 25 iterations, as previously done by Antiga et
al[43]. This lower threshold coupled with the CTA intensity was determined by
comparing the segments generated from the CTA and OCT data. The area of the segment
from CTA and its corresponding OCT image were compared using the ‘group_calcAreas’
function in Simvascular (https://simtk.org/home/simvascular). If these areas did not
match, the threshold and CTA intensity were adjusted accordingly. This process was
completed on a patient to patient basis.
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Figure 5: Segments registered on the wire pathway (black line) according to vessel landmarks where possible.
Remaining segments are then oriented to wire pathway and rotated such that segment centroids align with the vessel
centerline (blue line). Vector from the image centroid to the upper-left hand corner was also tracked and plotted (red).

2.2.4 Model Assembly

OCT segments from the stented region were coupled with CTA segments from
the distal and proximal regions of the stent to form the entire vessel. CTA segments of
branches within or near the stented region were created and added to the vessel as well
since OCT was not conducted for these side branches. 3D representations of the
proximal and distal regions to the stent were created using ITK-Snap and VMTK. These
regions were queried using customized Matlab scripts to create orthogonal segments
defining the vessel lumen. The same Matlab scripts were used to create segments that
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defined the branches. The segments from CTA as well as OCT were imported into the
open-source software Simvascular. The total group of segments was then lofted and
blended to form a Parasolid model (Siemens, Plano, TX) of the entire flow domain as
seen in Figure 6. The follow-up model was constructed using the same process described
above except with lumen segments from the follow-up OCT images.

Figure 6: Combined segments from CT and OCT (a) are lofted along with the branch segments to form a Parasolid
model (b).

2.3 Computational Stent Implantation
A series of Boolean operations was used to virtually implant the DES into the
patient-specific vessels similar to those previously described by Gundert et al[44] (Figure
7). First, a thick version of either the Nobori, Promus Element, or Xience Prime stent
was created using SolidWorks (Solidworks Corp., Concord, MA). The length of the stent
was adjusted in accordance to the stent implanted in each patient. Next, the stent
contours from OCT images were used to create a model and shell with a thickness equal
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to that of the specific stent used in the case. This shell was then intersected with a thick
version of the stent to create a patient-specific stent model. Finally, this patient-specific
stent model was subtracted from the lumen model to generate a computational
representation of the blood flow domain.

Figure 7: Method of virtual stent implantation. Solid models of the outer surface of the stent and vessel lumen (e) were
lofted from the purple and green contours of the OCT images (a). The stent model was used to create a shell with the
thickness equal to that of the stent (b). The shell was intersected with the thick stent model (c) to create a patientspecific stent model (d). Subtracting the patient-specific stent model (d) from the lumen model (e) generated a
computational representation of the blood flow domain (f).

While this method is based off of the similar process created by Gundert et al[44],
the previous process did not account for malapposed struts within the lumen, thereby
leading to thickened representations of struts to an unrealistic dimension that could create
erroneous changes in local artery and stent morphology when used for subsequent CFD
simulations. Accounting for malapposed struts was a novel aspect of this study. The
difference between the two methods can be seen in Figure 8.
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Figure 8: Model produced from Gundert et al that does not account for malapposed struts (left). Model produced from
current method that can create malapposed struts (right).

2.4 Steps Performed to Assure Accuracy During Vessel Reconstruction
In order to assure that the vessel reconstruction and stent implantation processes
were performed accurately, a series of checks were performed throughout the entire
process as shown in Figure 9.
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Do any slices have abnormalities,
dissections, or overlapping areas?

If no, use the
normal number
of points in
contour for slices

If yes, increase
the number of
points in contour
for that slice

Do the vessel and
stent segments
overlay the CT
volume properly?

Run
Reconstruction
Code

If no, double
check
Simvascular
shifts and
landmark points

If yes, loft
segments

Do lumen and
stent contours
match OCT
images when
overlayed in
Simvascular?

Implant stent and
slice the
proximal, middle,
and distal stented
regions. Run
orient.m

If no,
troubleshoot

If yes, proceed

Does the stent
alignment match
the OCT image?

Do the contour
areas match
the OCT image
areas?
If yes, run
simulations

If yes,
proceed

If no, rotate the
stent in
SolidWorks

If no, check
mm/pixel
calculation

Key

Check Points

Process

Figure 9: Processes for assuring accuracy while creating patient-specific coronary models.

First, the OCT images were analyzed by visual inspection to determine if there
were any images with contours containing abnormalities (e.g. dissections, protrusions and
overlapping edges). Such abnormalities, as depicted in Figure 10, can create inaccurate
segments and cause interpolation errors when lofting the segments. To prevent errors
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while still maintaining the correct contours, the number of points used to create the
segment is increased in images with such abnormalities.

Figure 10: Abnormality (i.e. dissection) in the lumen contour that requires an increase in segment points.

Next, the lumen contour segments were overlapped with their respective stent
contour segments in Simvascular to determine if they were in the correct orientation.
This assured that the correct path and rotation was used to align the stent contours. Then,
also in Simvascular, the areas of the segments were determined and compared to the
areas of the contours on their respective OCT image. This step confirms that the
millimeters per pixel calculation determined using ImageJ was correct. Next, the final
combination of OCT and CTA segments were superimposed on the entire CTA volume
in Simvascular. This step assures that the landmarks used to determine the transducer
path were correct. Also, Simvascular uses a coordinate system with an image origin at
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(0,0,0); however ITK-Snap and VMTK use the NIFTI coordinate system, and the
centerline generated from these programs will also be in this coordinate system.
Therefore, the coordinate shifts provided in Equation 7 were applied to convert between
NIFTI and Simvascular coordinates where (Xsp,Ysp,Zsp) are the spacings in the X,Y,
and Z directions, (Xo,Yo,Zo) are the coordinates of the Image Position (Patient) field
(0020,0032) of the most superior image, and Nsl is the number of slices in the data set.
These shifts are assuming that VolView places the image origin at (-0.125,-0.125,-0.125)
and images are 512x512. If these shifts are performed properly, the segments will line up
with the stented vessel in Simvascular.
(

)

(

)

(

)

Equation 7: Conversion between NIFTI and Simvascular coordinates

Finally, using a novel technique, it must be assured that the stent is accurately
placed circumferentially within the vessel model. To do this, an initial model of the
stented vessel is created using the steps mentioned above, and quickly evaluated without
running a CFD simulation. Instead, a vtk model of the stented flow domain is loaded into
Paraview (Los Alamos National Laboratory, www.paraview.org), and three slices are
made, one each in the proximal, distal, and middle regions of the stent. The slice
locations are taken from the lumen OCT segments used by Simvascular in the model
creation process. Using a custom Matlab program, the struts in the slices are compared to
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the strut shadows produced in the analogous OCT images and a degree of rotation is
calculated. The three degrees of rotation are averaged and the stent is then rotated
accordingly in Solidworks. The Boolean operations performed for virtual stent
implantation are then conducted again, if needed, using the rotated version of the stent
(Figure 11).

Figure 11: OCT image (left). Slice from initial virtual stent implantation with struts not matching OCT image (middle).
Slice after applying a specific rotation to the stent in Solidworks to better match the OCT image (right). * = guidewire
artifact.  = stent strut.

2.5 Specification of CFD Boundaries Conditions and Simulation Parameters
Post-stent and follow-up models were subjected to a canine pulsatile blood flow
waveform acquired from the left anterior descending coronary artery[45]. This blood
flow waveform is associated with Reynolds and Womersley numbers which made it
applicable in many previous computational studies[46]–[49]. The mean blood flow
through the stented artery was determined using cardiac output and assuming the
coronary arteries received 5% of the cardiac output, of which the right and left coronary
arteries received 16% and 84%, respectively[21], [50]. For patients whose cardiac output
was not obtained, cardiac output and mean blood flow through the stented artery was
determined using cardiac index and body surface area. The flow waveform was then
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scaled to match the mean blood flow of the specific vessel and introduced at the model
inflow face as a time-varying Womersley velocity profile. For all simulations, blood was
assumed to be a Newtonian fluid with a viscosity and constant density of 4 cP and 1.06
g/cm3, respectively.
The flow split between the main vessel and subsequent branches was calculated
assuming shear stress autoregulation (i.e. Murray’s Law). Murray’s Law states that when
a parent vessel branches into daughter vessels, the cube of the diameter of the parent
vessel is equal to the sum of cubes of the diameters of the daughter vessels[2]. This
represents an ideal branching pattern that optimizes energy and metabolic need, and
appears to be mediated by variations in artery caliber induced by WSS. Therefore, WSS
was assumed to be equal in the main vessel and branch vessels as shown in previous
studies by Williams et al[2], [49]. Assuming blood flow is fully developed, and has a
constant velocity profile, WSS can be estimated by Equation 8 where τ is WSS, µ is
viscosity, Q is average flow, and r is the lumen diameter.
Equation 8: Estimation of wall shear stress
As previously stated, WSS for the main vessel and branch vessel are set equal to obtain
the flow distributions to each coronary artery branch.
A three-element Windkessel representation was introduced on the outlets of the
models in order to replicate the physiological influence of the arterial tree distal to the
branch being examined. The three-element Windkessel model can be described by three
main parameters Rc, C, and Rd[2]. Rc is the characteristic impedance representing the
resistance, compliance, and inertance of the proximal artery of interest, C is the arterial
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capacitance and accounts for the sum of the compliance of arteries beyond the model
outlets, and Rd is the distal resistance in the absence of ventricular contraction[49].
Together, Rc, Rd, and the time-varying resistance to blood flow resulting from ventricular
contraction can be calculated as the ratio of mean blood pressure and mean blood flow.
In the absence of ventricular contraction using the impulse response method
demonstrated by Van Huis et al., Rc and Rd constitute the zero hertz impedance (Z0). Z0
is between 22%-65% less than the total resistance value[51]. Therefore, the mean blood
pressure and mean flow for each patient was scaled by 65% for the data to be constrained
within the range presented by Van Huis et al. Rc is described by the average impedance
of frequencies above 7Hz and can be calculated by Equation 9 where Cph is the wave
speed, ρ is the blood density, and r is the vessel radius[51].

Equation 9: Characteristic impedance reflective of average impedance of frequencies
above 7 Hz
A wave speed of 6.7 or 8.6 m/s was applied to represent either a left circumflex or left
anterior descending canine coronary artery, respectively[52],[49]. Rc was calculated for
each outlet branch and Rd was calculated as the difference between Z0 and Rc.
Capacitance at each outlet was calculated using a Matlab program that determines pulse
blood pressure based on an inflow waveform, the calculated Rc and Rd values and an
initial estimate for C. Specifically, in the frequency domain, the Fourier transform of the
flow waveform was multiplied by impedance (Z) which is calculated as seen in Equation
10 f is the frequency, and C is the estimate of capacitance[53].

29

(

)

Equation 10: Impedance in the frequency domain
The maximum (systolic), minimum (diastolic), and difference between the
maximum and minimum (pulse pressure) is compared to the desired blood pressure
values. The capacitance value is adjusted knowing that lower compliance yields larger
pulse pressures and vice versa[54]. This method is further illustrated in Figure 12.

Figure 12: Using flow waveform, blood pressure, impedance spectra, and RCR parameters to replicate physiologic
behavior (Fm=mean flow, Pm=mean pressure, Rc=characteristic impedance, Rd=distal resistance, C=capacitance,
PPd=pulse pressure predicted by model, PPa=pulse pressure method). Image obtained from Westerhof, American
Phys. Society, 1999.
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2.6 Anisotropic Meshing of Patient-Specific Models
For each post-stent and follow-up model, an anisotropic mesh with unstructured
tetrahedral elements was created using an automated mesh generation program
(Simmetrix, Clifton Park, NY). A custom meshing macro allowed for different
maximum element edge sizes on different faces. This feature was used to place more
elements where they were most needed within the flow domain (i.e. the stent struts) and
fewer elements where a coarse density was sufficient (i.e. the intrastrut regions and
proximal and distal to the stent).
Mesh element sizes were determined based on the strut width of the specific stent
that was implanted. The minimum element size at the stent face was set to ¼ the strut
width. This assured at least four elements across the width of the stent. Previous studies
indicated that CFD results of the stented vessel model were independent of the mesh
density using the aforementioned mesh parameter[37].
Simulations were performed using a stabilized finite element method to solve
equations for conservation of mass (continuity) and balance of fluid momentum (NavierStokes). Four cardiac cycles were performed for each simulation to ensure convergence
with a maximum difference in blood pressure and flow between equivalent time points in
successive cardiac cycles of less than 1 mmHg and 1 mm3/s units, respectively.

2.7 Data Normalization
Each patient has a different flow rate to the artery as a result of its estimation from
anthropometric data, which may or may not be a true measure of coronary artery blood
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flow. This results in different values of WSS proximal to the stented region for each
patient (Figure 13).

Figure 13: Different values of WSS proximal to the stented region for three different patients.

To account for these differences, we facilitate individual and group comparisons by
normalizing (i.e. dividing) all WSS values for a given patient by an average WSS value
from upstream of the stent where it is assumed the vessel is closer to its native diameter.
This makes the range of WSS values between 0 and 1. This process generated a
normalized low WSS threshold of 0.3 based on previous studies indicating WSS less than
4 dynes/cm2 is an index of restenosis[21],[55], and a prior study relating NH to
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normalized WSS values after in rabbit iliac arteries[16]. While normalization can be
completed based off a number of indices including flow, normalizing to WSS provides a
universal threshold and range of values. Also, as previously mentioned, indices such as
flow are determined based on a number of assumptions. Normalizing based on such
values can provide a misrepresentation of WSS values.

2.8 Data Quantification Points
As conducted in previous studies, time-averaged WSS and OSI were calculated
and visualized over the last cardiac cycle for every post-stent and follow-up model.
2.8.1 Regional Quantification

The percentage of the post-stent and follow-up vessel surface exposed to timeaveraged WSS below 0.3 as well as OSI > 0.1[21], [56] was used to quantify the impact
of the implanted stent. Further quantification metrics include stent-induced area of low
WSS, area of low WSS per stent length, and stent-to-vessel area ratio. To calculate the
stent-induced area of low WSS, simulations and normalized WSS procedures were
performed on un-stented arteries created from post-stenting OCT data, but before
performing the Boolean stent implantation procedure, and subtracted from the stented
vessel. This eliminates the normalized low WSS areas that are caused by vessel
geometry, rather than that of the implantation of the stent (Figure 14).
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Figure 14: Low normalized WSS distributions produced by the vessel (left) compared to distributions produced by the
vessel and stent geometry (right).

The area of low WSS per stent length further normalizes the cases to account for
differences in the length of stents used in each patient. The stent-to-vessel area ratio
represents the area of exposed stent to the area of the lumen within the flow domain
where the stent was deployed.
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2.8.2 Local Quantification

Total NT at follow-up was quantified in Solidworks. This was completed by
subtracting the follow-up model volume from the post-stenting model volume. This
provides a measure of total tissue growth in the stented region.
NT was measured from the follow-up OCT images by subtracting the lumen
contour from the stent contour at equivalent circumferential locations relative to the
image centroid. This NT measurement was correlated with normalized time-averaged
WSS results obtained from the respective post-stent model along planes equivalent to
those at which the follow-up OCT images were acquired. This correlation was completed
at locations within 5 millimeter regions of the proximal, middle, and distal portions of the
stent (Figure 15). Locations within these regions had consistent scaffolding for each stent
(i.e. maximum number of struts circumferentially) since prior studies have indicated
differences in scaffolding can also influence the severity of NT. It was concluded that
there were not enough areas of OSI > 0.1 at post-stenting to perform the correlation with
NT at follow-up.
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Figure 15: Proximal, middle, and distal regions with maximum scaffolding that were isolated in an effort to correlate
post-stenting WSS and follow-up NT.

A process was created in order to assure that the NT measurement from the
follow-up model aligns in the same spatial location as the time-averaged WSS value from
the post-stenting model. First, both models were unwrapped using a process
demonstrated by Gundert et al[44]. During the unwrapping, the model is mapped to a (θ,
L) coordinate system where θ represents the angular position for 0-360 degrees in which
the zero degree position is chosen by the user, and L represents the length along the
vessel. The zero degree position is consistent for both the post-stent and follow-up
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model. An imaginary line running down the epicardial surface (i.e. outer wall) of each
artery was defined as the zero degree location. When saving the contours from the
follow-up OCT image and post-stenting WSS slice, arbitrary initial zero degree locations
are set. Next, we found the point nearest to the zero degree position (epicardial surface)
for both the follow-up OCT image and equivalent post-stent time-average WSS slice
from Paraview. The angle between the arbitrary initial zero degree locations and the
point nearest the zero degree position was determined for the OCT contour and WSS
slice using basic trigonometry. These angles were used as circumferential rotations. The
respective circumferential rotations were applied to shift the initial zero degree positions
to the epicardial zero degree position for the follow-up OCT contour and post-stenting
WSS slice. A plot was created illustrating that the shifted zero degree location matches
the epicardial zero degree location to assure that the shift was applied in the correct
direction. This process is illustrated in Figure 16.
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Figure 16: WSS results from CFD with the zero degree position line (epicardial surface) from unwrapping (a). Zero
degree line with Paraview slice (b). OCT image (c) and Paraview slice (d) are isolated to create their respective
contours (e and f, respectively). Rotations θ and α are determined for the OCT contour and Paraview slice between the
initial zero degree point and the epicardial surface. Rotations are applied to the lumen contour (g) and Paraview slice
(h) making the final zero degree position spatially consistent. 90°, 180°, and 270° positions are plotted to assure all
points are spatially consistent.

2.9 Statistical Analysis
GraphPad Prism (GraphPad Software, Inc.) was used to perform statistical
analyses between data points. Specifically, for each quantified metric (i.e. stent-to-lumen
area ratio, stent-induced area of normalized low WSS, etc.), a one-way ANOVA analysis
was performed to compare each of the stents to the other stents, that is, Nobori vs.
Promus Element, Promus Element vs. Xience Prime, and Nobori vs. Xience Prime. A
Tukey multiple comparisons test with a single pool variance was performed to determine
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significance between stents. Data was considered statistically significant if P < 0.05.
Data are expressed as means ± standard error of the mean (SEM).
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Chapter 3
Results
3.1 Patient-Specific WSS and OSI Results
3.1.1 Post-Stenting Results

Post-stenting CFD model results for low normalized WSS and OSI > 0.1 can be seen in
Figure 17 and 18, respectively, for the three types of stents studied as well as by case
number.
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Figure 17: Post-stenting distributions of low normalized WSS.
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Figure 18: Post-stenting distributions of OSI > 0.1.

Stent-to-vessel area ratios for the three stents can be seen in Figure 19. The
Nobori stent with its wider struts resulted in a significantly greater stent-to-vessel area
ratio (0.34±0.04) as compared to the Xience Prime (0.21±0.03), but not the Promus
Element (0.24±0.04) stent.
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Figure 19: Comparison of the stent-to-vessel area ratio, *=significance (mean±SEM).
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Distributions of normalized low WSS as a percentage of the entire artery model at
post-stenting were greatest for the Nobori, followed by the Xience Prime and Promus
Element stents (Figure 20; 24.1±6.7%, 18.4±4.6%, and 14±2.2%, respectively). These
differences did not reach significance. Distributions of normalized stent-induced low
WSS at post-stenting were greatest for the Nobori, followed by the Promus Element and
Xience Prime stents (Figure 21; 11.6±2.31%, 7.44±1.76%, and 6.3±1.2%, respectively),
but these differences did not reach significance.
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Figure 20: Comparison of the post-stenting normalized area of low WSS as a percentage of the entire vessel
(mean±SEM).
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Figure 21: Comparison of the post-stenting normalized stent-induced area of low WSS (mean±SEM).

The normalized stent-induced area of low WSS per stent length for the three
stents can be seen in Figure 22. The Nobori stent with its thick struts resulted in a
significantly greater normalized stent-induced area of low WSS per stent length
(2.0±0.41 mm2/mm) as compared to the Promus Element (1.05±0.27 mm2/mm), but not
for the Xience Prime (1.1±0.2 mm2/mm).
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Figure 22: Comparison of the post-stenting normalized stent-induced area of low WSS per stent length, *=significance
(mean±SEM).

The percentage of stent-induced OSI > 0.1 for the three stents can be seen in
Figure 23. The Nobori stent with thicker struts and greater stent-to-vessel area ratio
resulted in a significantly greater percentage of stent-induced OSI>0.1 (4.5±1.0%) as
compared to the Xience Prime (1.4±0.3%) and Promus Element (1.2±0.3%).
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Figure 23: Comparison of the post-stenting stent-induced OSI greater than 0.1, *=significance (mean±SEM).

3.1.2 Follow-up Results

Follow-up CFD model results for low normalized WSS and OSI > 0.1 for all three
stent models can be seen in Figure 24 and 25, respectively.
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Figure 24: Follow-up distributions of low normalized WSS.
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Figure 25: Follow-up distributions of OSI > 0.1.

Distributions of normalized low WSS as a percentage of the entire vessel model at
follow-up were greatest for the Nobori, followed by the Xience Prime and Promus
Element stents (Figure 26; 10.7±6.4%, 7.7±2.0%, and 5.8±1.2%, respectively). These
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differences did not reach significance. This order of outcomes based on stent model was
also found in normalized area of low WSS per stent length at follow-up (Figure 27;
0.7±0.5%, 0.4±0.1%, and 0.3±0.1%, respectively). These differences did not reach
significance.
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Figure 26: Comparison of the follow-up normalized area of low WSS as a percentage of the entire vessel (mean±SEM).

50

N o r m a liz e d A r e a o f L o w W S S
2

P e r S t e n t L e n g t h : F o llo w - U p ( m m /m m )
2 .0

2

m m /m m

1 .5

1 .0

0 .5

0 .0

N

o

b

o

ri

P

ro

m

u

s

E

le

m

e

n

t

X

ie

n

c

e

P

m
ri

e

Figure 27: Comparison of the follow-up normalized stent-induced area of low WSS per stent length (mean±SEM).

Post-stenting and follow-up CFD model results for low normalized WSS for all
three stent models can be seen side by side in Figure 28.
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Figure 28: Post-stenting and follow-up distributions of low normalized WSS.

For all groups of stents, the normalized area of low WSS decreased from poststenting to follow-up. This decrease in normalized area of low WSS between poststenting and follow-up was greatest for the Nobori (13.4±3.4%) followed by Promus
Element (7.2±1.6%) and Xience Prime (4.8±1.6%). The difference between the Nobori
and Xience Prime was significant (Figure 29). One patient (5010) had increased
distributions of normalized low WSS at follow-up compared to post-stenting. This was
due to tissue resorption in an area of the stented region, causing the area of the vessel to
increase, thereby further decreasing adverse WSS distributions.
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Figure 29: Comparison of the post-stenting and follow-up normalized area of low WSS as a percentage of the entire
vessel, *=significance (mean±SEM).

OSI > 0.1 as a percentage of the entire vessel model at follow-up was greatest for
the Nobori, followed by the Xience Prime and Promus Element stents (Figure 30;
5.2±1.2%, 4.9±1.0%, and 2.4±0.8%, respectively). The differences between stents did
not reach significance.
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Figure 30: Comparison of the follow-up OSI greater than 0.1 (mean±SEM).

For all groups of stents, OSI > 0.1 decreased from post-stenting to follow-up
(Figure 31). This decrease in OSI > 0.1 between post-stenting and follow-up was greatest
for the Nobori (4.8±2.2%) followed by Promus Element (1.0±0.4%) and Xience Prime
(0.4±0.4%). The differences between stents did not reach significance.
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Figure 31: Comparison between post-stenting and follow-up OSI greater than 0.1 (mean±SEM).

3.2 Post-Stenting WSS and Follow-Up Tissue Growth
3.2.1 Comparison Between Post-Stenting WSS and Follow-Up Neointimal Tissue

Inverse correlations were observed between values of post-stent WSS and NT at
follow-up for all stents. These correlations are determined using linear regression
analysis producing a correlation coefficient and slope value, as demonstrated in previous
studies[39], [41]. Figure 32 shows a representative version of the correlation between
post-stenting WSS and NT at follow-up.
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Figure 32: OCT image at follow-up (a) with circumferential NT measurements starting at the zero degree position (b).
Paraview slice at post-stenting (c) with circumferential WSS measurements starting at the zero degree position (d).
Correlation between post-stenting WSS and NT at follow-up (e).

Correlations for all quantified regions can be found in Figures 33-38. Excluding
the distal and middle regions, this inverse correlation was greatest for the Nobori stent.
Also, for all regions excluding the proximal region, the inverse correlation was least for
the Xience Prime stent.
When combining the data from the proximal, middle, and distal regions, the
inverse correlation between post-stenting WSS and NT at follow-up was greatest for the
Nobori (-0.019±0.001 mm/Pa) followed by Promus Element (-0.017±0.003 mm/Pa) and
Xience Prime (-0.008±-0.003 mm/Pa). The difference between the Nobori and Xience
Prime was significant (Figure 38).
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Figure 33: Distal region comparison of inverse correlations of post-stenting WSS and follow-up neointimal thickness
represented by the r-value and slope from regression analysis (mean±SEM).
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Figure 34: Middle region comparison of inverse correlations of post-stenting WSS and follow-up neointimal thickness
represented by the r-value and slope from regression analysis (mean±SEM).
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Figure 35: Proximal region comparison of inverse correlations of post-stenting WSS and follow-up neointimal
thickness represented by the r-value and slope from regression analysis (mean±SEM).
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Figure 36: High WSS region comparison of inverse correlations of post-stenting WSS and follow-up neointimal
thickness represented by the r-value and slope from regression analysis (mean±SEM).
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Figure 37: Low WSS region comparison of inverse correlations of post-stenting WSS and follow-up neointimal
thickness represented by the r-value and slope from regression analysis (mean±SEM).
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Figure 38: Combined proximal, middle, and distal regions comparison of inverse correlations of post-stenting WSS
and follow-up neointimal thickness represented by the r-value and slope from regression analysis, *=significance
(mean±SEM).

59
3.2.2 Total Neointimal Growth at Follow-Up
The decrease in volume of the vessel during the follow-up is shown in mm3
(Figure 39) and as a percentage change from post-stenting to follow-up (Figure 40).
Decrease in volume in mm3 at follow-up was greatest for the Nobori, followed by the
Promus Element and Xience Prime stents but differences did not reach significance
(Figure 39; 14.7±4.2 mm3, 6.4±3.8 mm3, and 6.2±3.2 mm3, respectively). This order of
outcomes based on stent model was also found in percentage decrease in volume from
post-stenting to follow-up but differences did not reach significance (Figure 40;
12±3.9%, 5.8±3.5%, and 5.2±2.3%, respectively).
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Figure 39: Comparison of the change in volume from post-stenting to follow-up (mean±SEM).
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Figure 40: Comparison of the change in volume from post-stenting to follow-up as a percent of post-stenting volume
(mean±SEM).

61

Chapter 4
Discussion
4.1 Review of Specific Aims and Summary of Major Findings
The objective of this study was to evaluate three current generation stent
geometries via WSS patterns, and their respective impact on NT, a component of
restenosis. To satisfy this objective, OCT and CTA data were obtained just after stent
implantation and at 9-months follow-up. CFD simulations were performed on the poststent and follow-up patient-specific models to analyze the effects of the Nobori, Promus
Element, and Xience Prime stents via their WSS distributions and respective NT.
Furthermore, this thesis was separated into three aims to better understand the effects of
the stents, that is, evaluate the relationship between low WSS distributions and stent
geometry, compare post-stent and follow-up low normalized WSS, and the correlation
between post-stent WSS and follow-up NT.
The first aim of this study was to use patient-specific models to confirm previous
idealized studies regarding the amount of low WSS and stent design. Stent design has
been shown to influence local distribution of adverse WSS and correlate with NT. For
example, Gundert et al performed CFD simulations on idealized stented coronary
arteries. Their study created a hierarchy of stent design factors that can lead to adverse
WSS distributions. The authors found that strut thickness had the greatest impact on
adverse WSS distributions. When this attribute was similar among stent designs, the
stent-to-lumen area ratio, angle of struts relative to the primary direction of blood flow,
and arrangement of connector elements were also predictive of adverse WSS

62
distributions. Using patient-specific models, we were able to confirm the conclusions
from the idealized study. The data presented in the current work indicates that the greater
stent-induced low normalized WSS in the Nobori (n=6) compared to the Promus Element
(n=8) and Xience Prime (n=8) is attributed to the larger strut thickness and increased
stent-to-lumen area ratio. While the strut thickness for the Promus Element and Xience
Prime are the same, the difference in low normalized WSS per stent length may be
caused by the increased number of connectors in the Xience Prime.
The second aim of this study was to compare post-stent normalized low WSS
with follow-up normalized low WSS. During the follow-up period, tissue grows atop and
around the stent struts. This tissue growth should return the WSS distributions closer to
the arteries’ native values, decreasing the consequences of adverse WSS distributions.
This aim was completed by comparing the low normalized WSS at post-stent and at
follow-up for each patient. The pronounced reduction in normalized low WSS from poststent to follow-up in the Nobori stents can be attributed to its thicker stent struts. Thicker
struts provide more space for the tissue to grow. Therefore, the Nobori was anticipated to
yield greater NT compared to the thinner struts of the Promus Element and Xience Prime.
The third aim of this study was to evaluate post-stent WSS and follow-up NT.
Adverse distributions of WSS triggered by stenting can cause increased NT leading to
restenosis. In order to complete this aim, NT measurements from follow-up models were
correlated with WSS measurements from the post-stent model. The correlation between
post-stent WSS and follow-up NT could be attributed to the mechanism of action for the
specific elution agent as previously suggested[39], [41]. NT leading to restenosis is a
process dictated by arterial wall remodeling as well as proliferation of smooth muscle
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cells. Limus-based elution agents are thought to inhibit cell migration leading to NT by
blocking the activation of mTOR, a protein kinase that plays a critical part in the
signaling pathway that regulates cell growth[57],[58]. Though limus-based DES agents
are thought to inhibit NT regardless of WSS, our results show a potential inverse
correlation with WSS for the biolimus-eluting Nobori. In contrast, the more favorable
stent geometries of Promus Element and Xience Prime were associated with less of an
influence of adverse WSS on NT.
Coupled with the mechanism of action for the elution agent, the correlation
between post-stent WSS and NT at follow-up may be affected by stent geometry. The
Promus Element and Xience Prime stents use the same drug-elution agent and coating,
however, have different geometries. Our results for the Promus Element and Xience
Prime show that there is a difference, though not significant, in correlation between poststent WSS and follow-up NT. These differences may be caused by different WSS
distributions that in turn affect the amount of drug absorbed in the vessel wall.
All arteries have a homeostatic WSS value. After stent implantation, WSS values
within the stented region will typically decrease since all stents need to be implanted to a
diameter larger than the native vessel diameter. Arteries undergo autoregulation (i.e.
tissue growth or resorption) in an effort to return the WSS distributions to more
preferential native range of values. Knowing that the Nobori has thicker struts compared
to the Promus Element and Xience Prime, one would expect greater flow disruptions
resulting in greater areas of adverse WSS, which was illustrated in the current results.
This is also likely the stimuli behind greater tissue growth compared to the thinner struts
of the Promus Element and Xience Prime, even though all the stents have limus-based
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elution agents. Due to the increased amount of adverse WSS distributions in the Nobori
compared to the Promus Element and Xience Prime, it seems there is a threshold beyond
which the effects of the drug-elution agent are mitigated.
After WSS distributions return to their homeostatic value, there is a possibility of
neointimal tissue continuing to grow. This is known as late catch-up and can be
attributed to delayed healing and local inflammatory reactions to the polymer carrier.
Long-term studies conducted by Hagiwara et al found that the Nobori maintained
efficacy after 15 months and can reduce rates of late restenosis due to its polymer
degradation[59]. These long-term effects were not within the scope of the current study.
From these results, it seems that while the DES elution agent can be an important
factor in NT, stent geometry (e.g. strut thickness) still plays a vital role in the effect of
WSS on NT.
4.2 Relationship to Previous Work Underscoring Unique Contributions

Using the same CFD approach as Ellwein et al, this project was able to confirm
idealized findings from Gundert et al regarding adverse WSS distributions and stent
geometry using a large population of patient-specific models[34]. This confirmation
helps prove that stent design factors (i.e. strut thickness, number of connectors) have an
effect on the WSS distributions in human coronary arteries.
There have been several small studies correlating WSS distribution to sites of NT
for first generation DES. Gijsen et al presented a study using 3-dimensional lumen
reconstruction and computational fluid dynamics to analyze the relationship between
blood-flow induced WSS and NT in 6 patients with first-generation sirolimus-eluting
stents. Linear regression showed an inverse relationship between NT and WSS.
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Papafaklis et al conducted a study analyzing the relationship between WSS and
NT following the implantation of sirolimus- and paclitaxel-eluting stents, both of which
are first-generation DES. These findings were compared to the results produced by bare
metal stents. The study involved 30 total patients, 10 per stent group. Results showed a
significant inverse relationship between WSS and NT for the paclitaxel-eluting stents.
However, contrary to the before mentioned study (Gijsen et al), this relationship was
absent in the sirolimus-eluting stents. The current project is the largest known study to
date to analyze the impact of WSS on NT at several regions of the stented artery (i.e.
distal, middle, proximal, high WSS, low WSS) in the setting of current generation DES.
Similar to prior findings correlating WSS to NT in 6 patients with sirolimus-eluting DES
by Gijsen et al, the inverse correlation in areas of low WSS were present for the
biolimus-eluting Nobori (n=6) and the everolimus-eluting Promus Element (n=7) and
Xience Prime (n=6).
As mentioned throughout this thesis, there are several aspects of this study that
are novel contributions to science. These contributions are summarized in Table 2.
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Novel Aspect of Thesis

Accounting for
malapposed struts

Implanting stent based
on circumferential and
longitudinal locations

Description
When virtually
implanting stents into a
patient-specific artery,
previous methods did
not account for
malapossed struts,
thereby leading to
thickened
representations of
struts to an unrealistic
dimension.
When virtually
implanting stents, stent
placement is based on
the longitudinal
location in the artery as
well as the
circumferential
locations of the struts.
This process assures
for an accurate stented
model.

Analyze and visualize
OSI > 0.1

A custom program
allows for the
calculation of the
percentage of the
vessel above a
threshold. Program
also isolates this area
of the vessel for
visualization.

Distinguish between
adverse wall shear stress
distributions caused by
local vessel geometry
and the implanted stent

To calculate the stentinduced area of low
WSS, simulations were
performed on unstented arteries created
from and subtracted
from the stented
vessel. This eliminates
the normalized low
WSS areas that are
caused by vessel
geometry, rather than
that of the implantation
of the stent.

Image

Previous method (left) and current method
(right)

Previous method (middle) and current method
(right) shifting the stent based on the OCT
image (left) * = guidewire artifact.  = stent
strut.

OSI > 0.1

Low normalized WSS distributions produced
by the vessel (left) and by the vessel and stent
geometry (right).
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Determining patientspecific stent-to-vessel
area ratio

The stent-to-vessel
area ratio represents
the area of exposed
stent to the area of the
lumen within the flow
domain where the stent
was deployed
Stented coronary artery with area of the stent
in contact with the lumen wall highlighted
silver

Additions to the
reconstruction code

In an effort to make the
reconstruction code
more robust, additions
including being able to
isolate OCT contours
of different color
schemes, accepting
OCT images of
different sizes, and
adding an input of the
pixel per millimeter
ratio of the OCT image
series.

OCT images with different color schemes

Table 2: Summarizing unique contributions this study presented.

4.3 Limitations

The current project should be interpreted within the constraints of several
potential limitations. CT data was only acquired immediately post-stenting. This study
did not take into consideration the possibility of any major structural changes in the
arteries proximal or distal of the stented region during the 9-month follow-up. This was
based on the knowledge that structural changes would be minimal. Also, this assumption
greatly decreased computational time. The number of slices used here (one image per
millimeter) is consistent with the current norm implemented during quantification
clinically. However, the OCT imaging system has the capability to obtain 10 images per
millimeter. Also, our methods do not take into account the elution distributions
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implemented by the stent geometry or release kinetics of the drugs as it was not within
the scope of this study. Finally, this study does not distinguish between types of tissue
growth at follow-up. Due to the high resolution of the OCT image, it is possible to
delineate and quantify superficial plaque with accuracy. This delineation is completed
using the different intensities of various types of plaque. While this was not in the scope
of this study, it is starting to be performed similar to Celi et al[60]. This is an additional
limitation of this study, but will likely be addressed in future work from our lab that
leverages the advancements made in this thesis.

4.4 Future Directions
Promus Element, on average, proved to be a superior stent in terms of WSS
distributions. However, initial studies indicate that not all patients received the optimal
DES according to CFD. Local features in the artery can factor into adverse WSS and
correlate with NT depending on the DES elution agent. One must determine what
specific factors promote the success of one DES compared to another in terms of WSS.
Also, if the process described in this thesis could be streamlined, the optimal stent could
be determined case by case at bedside.
In order to fully understand the effects of different DES on WSS and NT, studies
must be done to determine the relative contribution of the stent geometry and respective
elution agent. While keeping either the stent design or elution agent constant, one will be
able to hypothesize on the specific effects that each has on NT. This study has the
potential to find an optimal pairing of geometric factors and elution agents that could
improve the restenosis rate.
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Appendix
1. Initial Programs and Set-Up
a. The following arrangement of directories and programs should be used for
all cases, both post-stenting and follow-up. This arrangement can also be
seen in the demo files in the Code Repository.

Post (or follow-up)
mLCX – This directory contains the surface and centerline points
from CT data found using the instructions in the documents
Master_Simulation_Document.doc and
Steps_to_Segmenting.doc created by Laura Ellwein.
Post
adjacency_blkdiag.m
advanced_dijkstra.m
calculate_regionprops.m
circum_interpolate_fixed.m
dat2jpg.m
find_pathpoints.m
func_Write_Axial_Spline_VTP.m
isolate_image_contours.m
isolate_image_contours_green_purple.m
jpg2dat.m
LCX_csa.m
masking_extras.m
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masking_extras_AB.m
OCT_group_content_creator.m
OCT_path_creator.m
OCT_segment_creator.m
OCT_segment_creator_smooth.m
pixel_sorter.m
plotpoints.m
point_order.m
refine_transducer.m
refined_shortest_path.m
rotate_dist_prox_slices.m
rotate_OCT_slices.m
rotate_OCT_slices_trans.m
rotate_OCT_slices_trans_final.m (follow-up only)
rotate_refined_transducer.m
save_normals_points.m
shortest_path_dijkstra_method.m
testABmask.m
TRACE_MooreNeighbourhood.m
trans_interp.m
Post_Stent
calculate_regionprops.m
isolate_image_contours.m
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isolate_image_contours_green_purple.m
masking_extras.m
OCT_group_content_creator.m
OCT_path_creator.m
OCT_segment_creator.m
OCT_segment_creator_smooth.m
pixel_sorter.m
point_order.m
rotate_OCT_slices_trans.m
truncate.m
b. Program: simvas_shift.m
i. Function: The coordinate system in Simvascular coincides with
that of VolView, using an image origin at (0,0,0); however ITKSnap uses the NIFTI coordinate system to save meshes, and
likewise the centerline generated from VMTK will be in this same
coordinate system. Therefore a coordinate shift is used to convert
between NIFTI and “Simvascular” coordinates.
ii. Input: Size and spacing of DICOM image sequence can be found
in Volview (Figure 41). Superior image position can be found by
first opening the image sequence using ImageJ (Figure 42). Scroll
to the most superior image and open the image info (ctrl+I) and
scroll to “Image Position (Patient) Field (0020,0032)”. All the
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aforementioned parameters are input into the pop-up GUI when the
program is run.

Figure 41: 3D volume in Volview showing the size in voxels and image spacing.

Figure 42: Using ImageJ, determine the Image Position for the most superior image.
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iii. Output: Xshift, Yshift, and Zshift are displayed in the Matlab
command window (Figure 43).

Figure 43: X, Y, and Z shifts output in Matlab.

2. OCT Image Processing
The following programs should be run for the post-stenting and follow-up cases.
a. Program: isolate_image_contours.m
i. Function: Isolates the lumen or stent contours from a series of .jpg
images. Make sure the program is isolating the correct contour
(lumen or stent). If it is not, select the correct
isolate_image_contours.m. The programs are separated by which
color contour they isolate.
ii. Input: The following parameters should be inserted into the popup GUI: starting number of the .jpg images, threshold for
converting to binary lumen images, and if the program should
show the original image. Segment matrix should correspond to the
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range and interval of the OCT image series (This will be the same
throughout the entire case). A representation of the segment
matrix can be seen in Figure 44. Also, at line 48, the name of the
images being loaded should match the header of the OCT images
as seen below.

Figure 44: Naming the slice and creating the segment matrix.

iii. Output: Each resulting image is saved as
‘lumen_segs\lumen#.dat’, with the # referring to the slice number.
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b. Program: masking_extras.m
i. Function: Masks over all of the unwanted parts of the images,
including headers, footers, and measurement markings.
ii. Input: Segment matrix should correspond to the range and
interval of the OCT image series as previously described.
iii. Output: Each resulting image is saved as the file
‘masked_segs\masked#.dat’.

c. Program: dat2jpg.m
i. Function: Convert ‘masked_segs\masked#.dat’ to
‘masked_segs\masked#.jpg’. Check image to make sure that all
unwanted parts of image are removed. Also, make sure that the
contour is completely filled. If not, manually edit in paint.
ii. Input: Segment matrix should correspond to the range and
interval of the OCT image series as previously described.
iii. Output: Each resulting image is saved as the file
‘masked_segs\masked#.jpg’.

d. Program: jpg2dat.m
i. Function: Convert edited ‘masked_segs\masked#.jpg’ to
‘masked_segs\masked#.dat’.
ii. Input: Segment matrix should correspond to the range and
interval of the OCT image series as previously described.
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iii. Output: Each resulting image is saved as the file
‘masked_segs\masked#.dat’.

e. Program: point_order.m
i. Function: This program orders the points on the boundary of the
filled contour delineated by the segment. Determines the centroid
of the filled segment and converts all pixels to xyz coordinates.
Note that TRACE_MooreNeighbourhood.m must be in the
‘masked_segs’ directory.
ii. Input: An even multiple of four that will equal the number of
circumferential resolution and the number of millimeters per x and
y pixel (determined from ImageJ). Also, the segment matrix is the
same as previous programs. If the OCT image has an anomaly
(dissection, overlapping tissue, etc.) change the contour being
saved to ‘vesseln_one#’ instead of ‘vesseln_sparse#’ as seen in
Figure 45.

Figure 45: Saving the’ vesseln_sparse’ or ‘vesseln_one’, depending if the image has an anomaly.
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If you incur an error when lofting the segments in Simvascular,
you must decrease the amount of points in the segment by
adjusting the circled value below in ‘vessel_sparse#’ (Figure 46)
and save the contour using the adjusted ‘vessel_sparse#’. The
circled value can range from 2-8 (higher value corresponds to
fewer points being saved).

Figure 46: Adjusting the number of points being saved for a contour.

iii. Output: Each resulting contour is saved as the file
‘contours_centers/contour_#.dat’ and
‘contours_centers/center_#.dat’ and plotted (Figure 47).
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Figure 47: Illustrating the X, Y, and Z coordinates of contours.

3. Vessel Reconstruction
a. Overview: The following programs are used to reconstruct the stented
coronary arteries using OCT images. This series of vessel reconstruction
programs should be ran for post-stenting and follow-up cases. Before
running these programs, the vessel surface and centerline should be found
using the instructions in the document Master_Simulation_Document.doc
and Steps_to_Segmenting.doc created by Laura Ellwein. These programs
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must be run in order, as the inputs for the programs are the outputs of the
programs run before it.
b. Program: find_pathpoints.m (Option 1)
i. Function: This script determines the points at which slices are
located, both initially on the centerline and finally on the
transducer path. Distances between data centerline points are
calculated and saved in a vector. A vector of cumulative distances
is created. These points are interpolated to 0.1mm distances and
saved in ‘new_cl.dat’.
ii. Input: The centerline and surface from CT are loaded. Make sure
that the directories are consistent when loading these files. ‘Tript’
(distal) and ‘Branchpt’(proximal) are the two landmarks. These
points are determined from ITK-Snap (Figure 48).
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Figure 48: Determining the landmark positions in ITK-Snap and inserting them into Matlab.

“reg_points” is a matrix of 3 columns and X amount of rows where
X is the number of OCT images. Next,
“reg_points(Y,:)=new_xyz(tri_id,:)” and
“reg_points(Z,:)=new_xyz(branch_id,:)” are set where Y and Z
are the numbers of the OCT images (in series) at the distal and
proximal landmarks, respectively (Figure 49). “tri2branch_dist” is
the distance between the two landmarks. “dist2slice_ratio” is the
“tri2branch_dist” divided by the number of OCT images in
between the two landmark images. “start_dist” is the distal
landmark position minus the number of images before the distal
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landmark multiplied by the “dist2slice_ratio”.
“start_dist2slice_ratio” is the “start2tri_dist” divided by the
number of OCT images before the distal landmark image. Please
reference the Figure 50 for an example of how to set up the
aforementioned matrices.

Figure 49: Determining which OCT images correspond to the landmark positions.
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Figure 50: Creating the matrices for find_pathpoints.m.

iii. Output: Locations are saved as “reg_points.dat”. Points are
interpolated to 4mm to establish locations for transducer candidate
point locations, saved in “path_points4.dat”. These are located
distal and proximal to the stented region.

c. Program: LCX_csa.m (Option 1)
i. Function: Finds the cross-sectional area at each of the points
“new_cl.dat”, the 0.1 mm interpolation of points. This program
reads in data files from the vessel surface and centerline points,
and calculates the corresponding cross-sectional area.
ii. Input: Select the stented region in the GUI. The centerline and
surface from CT are loaded. Make sure that the directories are
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consistent when loading these files (i.e set-up of directories is
exactly like the example previously shown).
iii. Output: Cross-sectional area from the vessel surface and
centerline points within the stented region.

d. Program: rotate_OCT_slices.m
i. Function: Rotates the slices so they are positioned on the
centerline of the vessel at each of the points “reg_points.dat”. The
rotational matrices are found which would rotate the centerline
parallel with the vector [0,0,1]. These are applied in the reverse
direction to the slices thus registering them in 3D on the centerline.
To find the candidate points for the transducer, first the transducer
locations for the two landmarks are estimated from ITK-Snap. For
all other segments, candidate points for the transducer location are
chosen – 13 points equally spaced around the centerline at a radius
equal to the distance between the transducer and centroid. Finally,
the upper left hand corner is tracked.
ii. Input: The segment matrix is the same as previous programs. The
mm/pixel calibration needs to be inserted at the lines calculating
the “new_transducer” and “new_ul” as seen in Figure 51. This
value should be the same value used in point_order.m.
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Figure 51: Adding the mm/pixel ratio.

For the landmark positions, candidate points from ITK-Snap and
their corresponding OCT image number (in series) must be
inserted as seen in Figure 52.

Figure 52: Setting the candidate points (circled) for the landmark positions.

iii. Output: Transducer candidate points are saved as
“transducer_candidates\transducer_candidates_#.dat”. The upper
left hand corner points are saved as “real_ul\real_ul_#.dat”.
e. Program: LCX_csa.m (Option 2)
i. Function: Finds the cross-sectional area and resulting average
radius at each of the points ‘path_points4.dat’, spaced 4 mm apart
distal and proximal to the stented region. The radius is used to find
candidate points for the transducer location, 4 points equally
spaced at 1/3 radius away from the centerline, and 8 points equally
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spaced 2/3 radius away from the centerline. Center point is
included as well for a total of 13 points. Candidate points saved in
‘distal_proximal\dist_prox_#.dat’.
ii. Input: Select the distal/proximal region in the GUI. The
centerline and surface from CT are loaded. Cross-sectional area
and resulting average radius at each of the points
‘path_points4.dat’ is determined.
iii. Output: ‘Distal_proximal’ directory is created. Candidate points
are saved in this directory as ‘dist_prox_#.dat’.
f. Program: rotate_dist_prox_slices.m
i. Function: Rotates the 2D transducer candidate points
‘dis_prox_#.dat’ into the vessel to create 3D transducer candidate
points distal and proximal to the stented region.
ii. Input: The surface points from CT are loaded. Centerline
(‘new_cl.dat’) and center path points (‘path_points4.dat’) are
loaded. 3D transducer candidate points are created using the
candidate points (‘dist_prox_#.dat’) from LCX_csa.m.
iii. Output: 3D transducer candidate points are saved as
‘distal_proximal\dist_prox_candidates_#.dat’ and plotted as seen
in Figure 53.
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Figure 53: Transducer candidate points for the proximal and distal regions.

g. Program: shortest_path_dijkstra_method.m
i. Function: Determine the path of minimum bending energy
through the candidate points using a shortest path algorithm,
Dijkstra’s algorithm.
ii. Input: The segment matrix is the same as previous programs. For
the distal region, determine the number of locations and set ‘n’ in

94
the for loop to ‘1:number of locations’. Perform this same step for
the proximal region and set ‘n’ accordingly. The following
example in Figure 54 corresponds to Figure 53 (5 distal locations
and 2 proximal locations).

Figure 54: Setting up for-loops to properly determine transducer pathway.

iii. Output: Saves the candidate transducer points at a 0 degree offset
from the original transducer location (‘trans_start_ang0.dat’) and
the final transducer points (‘final_transducer_points.dat’).
h. Program: find_pathpoints.m (Option 2)
i. Function: Interpolates the points found in the shortest path
algorithm to 0.1mm and finds points spaced ~1mm apart. This
distance is approximate, because as with option 1, slices between
landmarks are then placed equally spaced on the centerline. This
spacing is used to place slices distal and proximal to the region
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between landmarks. Results are saved in ‘trans_interp_pts.dat’ and
‘reg_points_trans.dat’.
ii. Input: The centerline and surface from CT are loaded. Landmark
positions are the same from find_pathpoints.m (Option 1). Loads
the transducer points from ‘trans_interp_pts.dat’.
iii. Output: Program automatically saves ‘trans_interp_pts.dat’ and
‘reg_points_trans.dat’.
i. Program: refine_transucer.m
i. Function: Adapted from LCX_csa.m. Finds 12 new points around
each point in ‘reg_points_trans.dat’ according to a radius of 1.1
mm. The radius is used to find candidate points for the transducer
location, 4 points equally spaced at 1/3 radius away from the
centerline, and 8 points equally spaced 2/3 radius away from the
centerline. Center point is included as well for a total of 13 points.
Candidate points saved in
‘refined_transducer\refined_transducer_#.dat’.
ii. Input: The centerline and surface from CT are loaded.
‘Trans_interp_pts.dat’ and ‘trans_start_ang0.dat’ are loaded.
‘Refined_transducer’ directory is created.
iii. Output: Refined candidate points are saved in the newly created
‘refined_transducer’ directory as ‘refined_transducer_#.dat’.
j. Program: rotate_refined_transducer.m
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i. Function: Similar to rotate_dist_prox_slices.m, except that it now
applies rotations from 2D to 3D for the ‘refined_transducer_#.dat’
points from refine_transducer.m.
ii. Input: The surface data from CT is loaded. ‘Trans_interp_pts.dat’
and ‘trans_start_ang0.dat’ are loaded.
iii. Output: Output files are saved in the ‘refined_transducer’
directory as ‘refined_transducer_candidates_#.dat’.
k. Program: refined_shortest_path.m
i. Function: Similar to shortest_path_dijkstra_method.m, but now
uses ‘refined_transducer_candidates_#.dat’ from
rotate_refined_transducer.m.
ii. Input: The segment matrix is the same as previous programs. In
the first for loop, ‘n’ must go from 1 to the total number of refined
transducer candidate files in the ‘refined_transducer’ directory.
Program loads in the ‘refined_transducer_candidates_#.dat’ from
the ‘refined_transducer’ directory.
iii. Output: Shortest path points are saved in ‘refined_trans_start.dat’.
l. Program: find_pathpoints.m (Option 3)
i. Function: Interpolates the points found in the shortest path
algorithm to 0.1mm and finds points spaced ~1mm apart. This
distance is approximate, because as with option 1, slices between
landmarks are then placed equally spaced on the centerline. This
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spacing is used to place slices distal and proximal to the region
between landmarks.
ii. Input: The centerline and surface from CT are loaded. Landmark
positions are the same from find_pathpoints.m (Option 1and 2).
Loads the transducer points from ‘refined_trans_start.dat’.
iii. Output: Program automatically writes over ‘trans_interp_pts.dat’
and ‘reg_points_trans.dat’.
m. Program: rotate_OCT_slices_trans.m
i. Function: Rotates the slices so they are now positioned on the
transducer path of the LCX at each of the points
‘reg_points_trans.dat’. The rotational matrices are found which
would rotate the transducer to be parallel with the vector [0,0,1].
These are applied in the reverse direction to the slices thus
registering them in 3D on the transducer. In the final step, the
contour is rotated within the orthogonal plane such that the
transducer point, the centroid, and the point of intersection
between the centerline and the orthogonal plane align with each
other.
ii. Input: The surface data from CT is loaded. The segment matrix is
the same as previous programs. The program loads
‘trans_interp_pts.dat’, ‘trans_start_ang0.dat’ and ‘new_cl.dat’.
Coordinate shifts found previously are set as the ‘Xshift’, ‘Yshift’,
and ‘Zshift’, respectively.
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iii. Output: The directories ‘final_slice_points’, ‘projected_center’
and ‘final_center’ are created. Segments are saved in
‘final_slice_points\final_slice_points_#.dat’ and the new estimated
centers are saved in ‘projected_center\projected_center_#.dat’.
Finally, the vectors from the image centroid to the upper-left-hand
corner are plotted to allow for visual confirmation of slice location
as seen in Figure 55.

99

Figure 55: Final rotated segments with the centerline (blue) and transducer pathway (black). Also, the upper-left
hand corner of the images is tracked and plotted.

n. Program: OCT_segment_creator.m
i. Function: Create a group of segments that can be loaded into
Simvascular.
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ii. Input: The segment matrix is the same as previous programs.
Coordinate shifts found previously are set as the ‘Xshift’, ‘Yshift’,
and ‘Zshift’, respectively. At line 55, set the name you wish to call
the group (Figure 56).

Figure 56: Naming the group for Simvascular.

iii. Output: A group with the assigned name is created and saved in
the ‘groups’ file.
o. Program: OCT_group_content_creator.m
i. Function: This program creates the group contents file necessary
to load groups into Simvascular
ii. Input: At line 29, change the group name to match that of your
group (Figure 57). This file only needs to be created once. For
multiple group files in the ‘groups’ directory, manually edit the
group contents file.

Figure 57: Naming the groups in the group_contents file.
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iii. Output: The ‘group_contents’ file is saved. Move this file into
the ‘groups’ directory.
p. Copy ‘new_cl.dat’, ‘reg_points_trans.dat’, and ‘trans_interp_pts.dat’ into
the ‘Post_Stent’ directory. Perform the OCT Image Processing programs
from part two, this time isolating the stent contour.
q. Program: truncate.m
i. Function: Truncate the transducer wire pathway to only include
the stented region.
ii. Input: ‘reg_points_trans.dat’ is loaded into the program. At line
5, set the bounds of ‘r’ to only include the stented region (Figure
58). .
iii. Output: ‘reg_points_trans_trunc.dat’ is saved.
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Figure 58: Truncating the transducer pathway based on the stented region.

r. Run rotate_OCT_slice_trans.m (same program as step m), however, for
the stented region the program will load ‘reg_points_trans_trunc.dat’. No
changes need to be made to the code as this program is already set in the
demo files within the ‘Post_Stent’ directory.

4. Virtual Stent Implantation
a. Preprocessing: For preparation of the stent model, creating a thin-wall
model from the stent outer boundary, and flexing the stent model, see
instructions created by Timothy Gundert in
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Instructions_for_Implanting_Stents_in_OCT_model.doc. Note the
Boolean operations should be performed as described below.
b. Program: implant_stent_intersect.tcl
i. Function: Perform Boolean operations using Simvascular to
virtually implant the flexed stent into the vessel model.
ii. Input: Edit implant_stent_intersect.tcl using a text editor such as
Notepad. Scroll to the bottom of the document under the
‘Parameters’ section. Change the parameters to match the file
names and save the file. Parameters are defined below. In
Simvascular, navigate to the directory containing the files as well
as the implant_stent_intersect.tcl. To run the script, enter “source
implant_stent_intersect.tcl”. This command executes the file and
saves the output.

thinWallFileName- shell model
thickStentFileName- flexed thick stent
lumenFileName- lumen model
outputSolidFileName- desired output file name

5. Circumferentially Shifting Stent
a. Preprocessing: Perform a simulation using arbitrary boundary conditions
and write output files. Create the ‘wss.vtk’ file. Load the ‘wss.vtk’ file
into Paraview. Select and apply slices using locations from the ‘group’
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file. Save the slices and their respective OCT images in a separate
directory.
b. Program: orient.m
i. Function: This program provides circumferential shifts that can
be applied to the stent in Solidworks. This allows for a more
accurate model of the stented coronary artery.
ii. Input: ‘Slice’ is the name of the comma separated value
spreadsheet saved from the Paraview slice. ‘OCT’ is the OCT
image corresponding to Paraview slice. ‘Center_point’ is the
center of the slice and can be found in the ‘group’ file. Inputs can
be seen in Figure 59.
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Figure 59: Inputs for orient.m.

When the program is ran, the Paraview slice will appear. Using
the mouse, the user should select three strut locations. Next, the
OCT image will appear. The user should first select an estimation
of the contour center followed by three struts similar to the
Paraview slice locations.
iii. Output: Circumferential rotations will be displayed in the Matlab
command window. This program should be run for three locations
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(proximal, middle, and distal) within the stented region. Using the
rotate feature in Solidworks as seen in the Virtual Stent
Implantation Instructions by Timothy Gundert, rotate the stent
using an average of the three circumferential rotations. Repeat as
necessary.
6. Zero Degree Positioning for Local Quantification
a. Preprocessing: Apply and save Paraview slices for desired regions of
quantification. Slices should be applied to both the stented and unstented
model. Using the README.doc within the Unwrapping directory in the
Code Repository as well as the corresponding Matlab programs created by
Timothy Gundert, unwrap both the post-stent and follow-up models
assigning the epicardial surface as the zero degree location. Load the zero
degree text files (.dat files) into Paraview and save them as comma
separated value files in the directory containing the follow-up
reconstruction files.
b. Program: rotate_OCT_slices_trans_final.m
i. Function: The purpose of this program is to correlate poststenting WSS and neointimal thickness at follow-up. Specifically,
this program shifts the zero degree location to a spatially consistent
point at the epicardial surface between post-stenting and follow-up.
ii. Input: Created from rotate_OCT_slices_trans.m. All files being
input are the same from rotate_OCT_slices_trans.m. In addition,
the zero degree location (epicardial surface) from unwrapping is
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loaded. At line 137, ‘s’ should be set to the OCT image being
quantified (Figure 60).

Figure 60: Setting 's' to be the OCT image being quantified.

At line 267, ‘deg_shift’ is calculated (Figure 61). ‘Deg_shift’
determines which direction the rotation of the zero degree point is
applied.

Figure 61: Determing 'deg_shift', if the circumferential shift was applied in the wrong direction, comment out
'deg_shift' that was used and un-comment the other one. Note, one instance must be commented.

iii. Output: Figure 1 is the Paraview slice showing the initial zero
degree location (forest green point), epicardial surface (lime green
point), final zero degree location after rotation (black point), and
the final 90 degree location after rotation (blue point). The
epicardial surface and final zero degree location should be in the
same position (i.e. black point should be hidden behind lime green
point) as seen in Figure 62.
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Figure 62: Final zero and epicardial surface (lime green point) are in the same location. Initial zero degree location
(forest green point) and final 90 degree locations (blue point) are also plotted.

If they are not in the same position (Figure 63), the shift was
applied in the wrong direction and the ‘deg_shift’ that was used
must be commented out and the other one used. Re-run program if
necessary.
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Figure 63: Example of shift being applied in the wrong direction. Final zero degree location (black point) and
epicardial surface (lime green point) do not overlap.

‘Final_wss_angle’ is output and is a matrix where the first column
is the angle (0-359) and the second column is the WSS value
corresponding to that angle. Final WSS versus angle is also
plotted as seen in Figure 64. Copy and paste ‘final_wss_angle’
into a separate excel spreadsheet for linear regression analysis.
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Figure 64: WSS versus circumferential location plot.

‘Theta_deg’ is displayed in the Matlab command window and is
the circumferential shift for the follow-up thickness calculation.
c. Program: thickness.m
i. Function: Calculate the thickness of select OCT images at followup using the epicardial surface as the zero-degree location.
ii. Input: ‘Segment’ is the number corresponding to the OCT image
being quantified. Coordinate shifts found previously are set as the
‘Xshift’, ‘Yshift’, and ‘Zshift’, respectively. ‘Theta_deg’ is the
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circumferential shift found from rotate_OCT_slices_trans_final.m.
Inputs can be seen in Figure 65.

Figure 65: Inputs for thickness.m program.

iii. Output: ‘Thickness#’ is created and plotted where # corresponds
to the slice number (Figure 66). ‘Thickness#’ is a matrix where
the first column is the angle (0-359) and the second column is the
thickness value corresponding to that angle. Copy and paste
second column of ‘thickness#’ into the same spreadsheet as the
WSS results for linear regression analysis.
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Figure 66: Thickness versus circumferential location plot.

